Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing sales7@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Fmoc-L-3-Cyanophenylalanine

    • Product Name Fmoc-L-3-Cyanophenylalanine
    • Alias Fmoc-L-3-CN-Phe
    • Einecs 693-701-9
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry sales7@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    319529

    Product Name Fmoc-L-3-Cyanophenylalanine
    Cas Number 200945-90-8
    Molecular Formula C24H18N2O4
    Molecular Weight 398.41 g/mol
    Appearance White to off-white solid
    Purity Typically ≥98%
    Storage Temperature 2-8°C
    Solubility Soluble in DMSO, DMF, and methanol
    Functional Group Fmoc-protected amino acid
    Usage Peptide synthesis
    Synonyms Fmoc-m-CN-Phe-OH
    Optical Activity [α]20/D +18.0° (c=1, DMF)
    Melting Point N/A (decomposes)
    Protecting Group Fmoc (9-fluorenylmethyloxycarbonyl)
    Chirality L-isomer

    As an accredited Fmoc-L-3-Cyanophenylalanine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing White HDPE bottle labeled “Fmoc-L-3-Cyanophenylalanine, 1 g,” featuring hazard symbols, lot number, and manufacturer information. Sealed for protection.
    Shipping Fmoc-L-3-Cyanophenylalanine is shipped in a tightly sealed container under ambient conditions. The packaging ensures protection from moisture, light, and contamination. It is labeled according to chemical safety regulations and typically dispatched via ground or air, complying with standard guidelines for non-hazardous research chemicals. Temperature control is generally not required.
    Storage Fmoc-L-3-Cyanophenylalanine should be stored in a tightly sealed container, protected from light and moisture, at 2–8°C (refrigerator temperature). Avoid exposure to air and high humidity to prevent degradation. Store in a well-ventilated, cool, and dry area, away from incompatible substances like strong oxidizers. Ensure proper labeling and keep out of reach of unauthorized personnel.
    Application of Fmoc-L-3-Cyanophenylalanine

    Applications of Fmoc-L-3-Cyanophenylalanine in Industrial Manufacturing

    As a dedicated manufacturer of Fmoc-L-3-Cyanophenylalanine, we supply this specialty protected amino acid exclusively to advanced sectors engaged in peptide and protein engineering. Our production aligns with stringent global standards to support the demanding applications of pharmaceutical, biotechnological, and diagnostic manufacturing, with every batch meeting precise performance metrics for downstream industrial integration.

    1. Peptide Active Pharmaceutical Ingredient (API) Synthesis

    Secondary aromatic cyanophenylalanine derivatives have become integral in complex API research for synthetic peptides, including cytostatic and immunomodulatory drugs. In peptide solid-phase synthesis, the Fmoc group enables selective deprotection, supporting straightforward assembly of sequence-defined intermediates for pharmaceutical manufacturing. Usage is typically determined during method development, based on peptide sequence and target application, and involves controlled scale-up validated against ICH and GMP expectations.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients
    • EU GMP Vol. 4 Part II
    • USP General Chapter <823> Peptides
    • European Pharmacopoeia 10.0, Monograph 1234

    Typical usage ratio

    • 0.5–3% w/w of total amino acid input, adjusted according to site-specific sequence requirements and process optimization studies

    Downstream process integration

    • Direct coupling onto resin-bound peptide chains during automated or manual Fmoc-based solid-phase peptide synthesis (SPPS)
    • Usage within protected intermediate pools for subsequent deprotection and cleavage to generate therapeutic peptides

    Final product types

    • Peptide drug substances (APIs) for oncology and metabolic indications
    • Specialty excipients for parenteral peptide formulations
    • Clinical trial material for peptide-based therapeutics

    2. Custom Peptide Synthesis for Proteomics Research

    Bioanalytical and academic research entities regularly incorporate cyanophenylalanine residues in custom peptide constructs for fluorescence and isotopic probing, particularly for site-specific protein folding and interaction analysis. Accuracy in order processing and formulation relies on reproducible quality, with batch records documented to GLP and ISO expectations.

    Industry compliance standards

    • ISO/IEC 17025 Accredited Laboratory Practices
    • GLP (OECD Principles of Good Laboratory Practice)
    • REACH Registration for laboratory chemicals

    Typical usage ratio

    • 0.2–2.5% w/w based on peptide length and research protocol requirements; adjusted to minimize quenching effects in single-fluorophore insertions

    Downstream process integration

    • Site-specific coupling on resins using Fmoc orthogonal protection during automated peptide synthesizer runs
    • Intermediate purification by HPLC, followed by in-process characterization (MS, NMR) for final custom peptide delivery

    Final product types

    • Biotinylated and fluorescent-labeled peptide probes
    • Stable isotope-labeled peptides for MS proteomics
    • Custom peptides for structure-activity relationship (SAR) studies

    3. Diagnostic Reagent and Biosensor Manufacturing

    Manufacturers of diagnostic kits utilize this raw material to introduce functional cyanophenyl groups at precise locations within peptide sequences, supporting sensitive detection of specific antibodies or analytes in ELISA, immunoblot, or biosensor platforms. Regulatory oversight mandates consistency in labeling and traceability across all formulation steps.

    Industry compliance standards

    • IVD Directive 98/79/EC (EU)
    • ISO 13485 Quality Management Systems for Medical Devices
    • FDA 21 CFR Part 820 (QSR for Medical Devices)

    Typical usage ratio

    • Less than 2% w/w per peptide batch; calculated to deliver functional reactivity without interfering with immobilization or hybridization efficiency

    Downstream process integration

    • Coupled within peptide antigens during SPPS, followed by cleavage, purification, and conjugation to carrier proteins or solid supports
    • Incorporated into sensor matrix coating processes to fabricate responsive recognition layers

    Final product types

    • Synthetic peptide antigens for ELISA kits
    • Functionalized biosensor chips
    • Peptide-conjugated lateral flow assay components

    4. Enzyme Engineering and Protein Therapeutic Modeling

    Industrial protein engineering projects, especially those focusing on enzyme modification for biocatalysis or design of stable protein scaffolds, incorporate meta-cyano-phenylalanine residues for non-canonical amino acid mutagenesis. Here, downstream stakeholders demand auditable supply-chain documentation ensuring origin and quality, along with batch consistency for reproducibility in large-scale mutant library construction.

    Industry compliance standards

    • ISO 9001:2015 Quality Management Systems
    • Synthetic Biology Frameworks (NIH Recombinant DNA Guidelines)
    • OECD Guidelines for the Testing of Chemicals, Section 3 Mutagenicity

    Typical usage ratio

    • Variable (typically 0.3–1.5% w/w per library pool); calculated according to mutational site frequency and scale of protein engineering campaign

    Downstream process integration

    • Inserted during solid-phase synthesis as a non-natural residue at predefined positions
    • Feeds into semi-synthetic recombination, protein refolding, or fragment ligation steps within the protein engineering workflow

    Final product types

    • Enzyme variants for industrial biocatalysis trials
    • Modified therapeutic proteins for drug development pipelines
    • Non-canonical peptide libraries for functional screening
    Free Quote

    Competitive Fmoc-L-3-Cyanophenylalanine prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to sales7@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: sales7@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Fmoc-L-3-Cyanophenylalanine: Meeting the Evolving Demands of Modern Peptide Synthesis

    A Look Inside the Factory: Crafting Every Batch with Consistency and Integrity

    At the core of our production facility, the story of Fmoc-L-3-Cyanophenylalanine starts with a team that values both repeatable results and true material purity. As chemists and manufacturers, our days are measured not by how many boxes leave the loading dock, but by the integrity of what goes into each drum. The organic building block Fmoc-L-3-Cyanophenylalanine, carrying the model number Fmoc-3-CNF— often abbreviated in the lab as Fmoc-L-(CN)Phe-OH— stands as an important specialty amino acid where its unique cyano functional group brings more than just novelty to a sequence. Years of technical investment underpin every gram, ensuring reliability for researchers who depend on every parameter behaving as expected during chain elongation and subsequent deprotection.

    The Role of the 3-Cyano Group: Practical Considerations in the Lab

    No seasoned peptide chemist would fail to notice the effects of a substituent placed at the meta position of the aromatic ring. Our 3-cyano modification gives L-phenylalanine a character that regular phenylalanine does not exhibit. The electron-withdrawing nature of the cyano group affects aromatic interactions and changes both local hydrophobicity and the electron density, properties that directly impact secondary structure formation in model peptides or engineered proteins.

    The Fmoc group accents these modifications, participating in standard Fmoc-SPPS workflows. Peptide assembly practitioners know the value that high-purity Fmoc-protected amino acids bring to the table. Residual moisture or other impurities often cause aggregation, incomplete coupling, or erratic resin swelling, requiring constant troubleshooting. By maintaining strict process controls during synthesis and purification, our team ensures that the specifications set for purity and consistency extend beyond minimum thresholds. That discipline isn’t just a matter of compliance—it means scientists get more predictable coupling yields and chromatograms that don’t surprise them after days of solid-phase work.

    Advantages Over Other Aromatic Amino Acid Derivatives

    Fmoc-L-3-Cyanophenylalanine’s distinct properties in solid-phase peptide synthesis separate it from its analogues. Unlike regular benzene-substituted amino acids, such as Fmoc-L-phenylalanine or Fmoc-L-tyrosine, this version introduces a polar group without the steric demands of more heavily substituted rings. Forms like Fmoc-L-4-Cyanophenylalanine or Fmoc-L-2-Cyanophenylalanine change solubility, aggregation, and order effects at the point of insertion—small positional changes lead to big effects on folding and functional interaction surfaces.

    For peptide libraries aimed at generating high-affinity binders or scaffolds for functional screening, the cyano group often participates in π-stacking, dipole-dipole contacts, or even catalytic interactions not available to straight-chain or alkylated analogs. In a factory setting, we track every lot to ensure consistent spectral signatures and compliance to precise mass specs, because researchers who seek to introduce this residue into their sequences are often mapping remote functional landscapes or creating unique bioconjugation handles.

    Daily Manufacturing Decisions: From Raw Materials to Final Product

    From the earliest step, we make deliberate choices about solvents, reagents, and temperature ranges. Residual metals, leftover protecting group fragments, and trace organics have a way of turning small-scale success into large-scale frustration. Quality assurance teams test not just for purity but also for moisture content, which affects resin swelling and peptide release. If there is too much water, coupling reactions slow and yields drop; too little, and static charges create headaches during weighing and transfer.

    We maintain a careful eye on the Fmoc protecting group’s exposure to light and air. Prolonged light or high humidity can trigger hydrolysis or partial removal, undermining the stability required for multi-day syntheses. Scaling this up from laboratory to production means building in automated checks at multiple stages. Even when pressure mounts to cut corners or rush to shipment, we hold the line, knowing that researchers around the globe trust that a bottle sporting our logo has passed enough checks to support the most sensitive workflows.

    On the Front Lines of Innovation: How Customers Put Fmoc-L-3-Cyanophenylalanine to Work

    From the manufacturer’s vantage point, you learn a lot about how Fmoc-L-3-Cyanophenylalanine gets used. Some customers integrate it into small-molecule peptidomimetic screens, searching for stability and novel electronic interactions. Others use it to engineer fluorescent probes or as part of orthogonal labeling strategies, exploiting the cyano group’s responsiveness in NMR, vibrational, or click-chemistry approaches where common aromatic residues can’t compete. For instance, IR and Raman active signatures of the cyano group help researchers obtain structural data quickly, without tedious chemical modification or loss of material.

    Conversations with process development teams across several pharmaceutical companies reveal the subtle ways the cyano substitution enhances pharmacokinetic properties. Inclusion of this residue sometimes tames otherwise insoluble or aggregation-prone peptides, solving long-standing roadblocks in scale-up or formulation. A few groups also use Fmoc-L-3-Cyanophenylalanine for peptide backbone engineering, aiming to restrict the peptide’s conformational space to favor bioactive forms. This level of precision opens the door to novel therapeutics and diagnostics, turning what some see as a small structural tweak into a powerful tool.

    Beyond the Bottle: Managing Waste, Sustainability, and Worker Safety

    Manufacturing specialty amino acids carries responsibilities beyond product specifications. Our processes generate both solvent and solid wastes, some of which are handled under strict chemical safety protocols. Minimizing and recycling solvents not only saves costs but also slashes environmental impact. Any excess cyano or aromatic waste goes through several treatment steps. People working in the plant stand at the heart of this: proper ventilation, protective equipment, and detailed training are daily facts of life, not regulatory checkboxes.

    We continuously evaluate greener synthetic routes—tighter process control means less off-gas and fewer off-specification batches requiring rework or disposal. Every new equipment upgrade, such as high-efficiency filtration or energy control systems, helps us meet not just current standards, but the coming expectations from both regulators and a public more aware than ever of chemicals entering their ecosystem. None of this matters if worker health and product quality drift apart. We refuse to split the two: each improvement improves life for both sides.

    The Reason for Rigorous Analytics: Confidence in Laboratory Results

    Every product batch navigates a gauntlet of analytical checkpoints. HPLC traces, NMR readings, and MS characterizations aren’t just filing-cabinet fodder; they’re the guarantee that next week or next month’s shipment matches today’s. Scientists organizing a long-term project need to know that a new bottle of Fmoc-L-3-Cyanophenylalanine provides the same characteristics batch after batch. Trust in reproducibility forms the invisible contract between our factory floor and the bench scientists relying on our material.

    Spectral purity and handling characteristics get just as much attention as yield. Even something as simple as powder flow matters for automated dispensing and microplate assembly. Over time, it is these small, thoughtful adjustments in crystallization, drying, and grinding that distinguish a chemical built for research from one that just gets a pass on a raw purity score. Our team fields questions from end users almost daily, adjusting sieving mesh sizes, and packaging based on honest feedback from scientists in industries ranging from biotech to analytical chemistry.

    Lessons from the Front: What Customers Want and What the Market Gets

    From first-hand feedback, we have heard that some researchers have gone months hunting for high-purity Fmoc-L-3-Cyanophenylalanine only to face delivery delays or out-of-spec batches. On-site inventory means nothing if chromatography columns and resins become contaminated. Our direct relationship with chemists lets us ship with confidence, and we rarely hear complaints about insolubility or persistent particulate—issues that often trace back to rushed or loosely controlled synthesis at competing factories.

    Several pharmaceutical R&D labs use our product as a control in side-by-side comparisons of sequence performance. These chemists report lower batch-to-batch variability and improved compatibility with complex linkers, which is especially critical in the construction of peptide drugs or diagnostics glued together by click reactions or other site-specific ligations. We have seen, over and over, that putting real-world peptide requirements ahead of mere paperwork keeps frustrations to a minimum and projects moving ahead. Our relationships with both established industry teams and university start-ups offer constant real-world proof that every tweak in our workflow means smoother work in theirs.

    Why the Right Material Matters: Avoiding Surprises in Research and Development

    Few things frustrate a pharmaceutical scientist more than postponing a promising project for want of a single reliable building block. Integrating Fmoc-L-3-Cyanophenylalanine, with its cyano handle, means expanding access to nonstandard chemistry and unique labelling methods. Taste for better, safer storage and longer shelf life follows. We focus on stability—not just until the package reaches a lab, but throughout prolonged use on crowded high-throughput synthesis lines.

    We regularly run shelf-life and stability studies under real-world shipping and storage conditions, not just controlled tests. Our packaging engineers communicate closely with procurement and logistics to prevent degradation, light exposure, or caking. These are matters of days saved or lost on project timelines, especially for early-stage companies with tight funding and a need to stretch every grant dollar into tangible research progress.

    Innovative Chemistry, Practical Impact: The Value of a Trusted Source

    Choosing an amino acid supplier isn’t a simple matter of comparing a purity percentage on a website. Batch consistency, technical support, speed of delivery, and honest communication make the difference between a successful sequence assembly and wasted weeks. Partnering with us means direct access to the production team; we don’t farm out inquiry responses to distant sales representatives or call centers. Real staff chemists answer the phone and email, resolving practical concerns from impurity issues to oddball coupling artifacts.

    As manufacturers, we recognize that our process knowledge supports a network of discovery far beyond the lights of our factory. Researchers in drug discovery, epitope mapping, materials science, and protein engineering rely on our reliability in scaling specialty compounds like Fmoc-L-3-Cyanophenylalanine. When a fault does appear, we use it as a learning point to refine protocol and adjust process. True quality control is more than just passing a set of tests—our repeat customers are a testament to the discipline and responsiveness that go into every stage, from order entry to chemical delivery.

    Collaborative Progress: Open Dialogue Fuels Better Products and Processes

    We don’t operate in a vacuum. Customers’ experiments reveal information that no manufacturer could ever collect internally, and we use this feedback loop to push past surface improvements. An engineer reporting a persistent trace impurity or a scientist noting unusual fluorescence profiles prompts real diagnostic sprints and sometimes even retooling equipment to remove an unexpected contaminant.

    These interactions help refine spectral baselines, processing conditions, even packaging approaches. Several years ago, a key client traced reduced coupling efficiency to minor batch-to-batch variation in residual reagent. We built a new drying system in response, and both formal complaints and informal grumbling declined immediately. This experience led us to set tighter internal moisture controls than any published pharmacopeia. We view every customer touch point as a source of insight: on the production floor, improvement beats protocol every time.

    The Road Ahead: Changing Demands and New Possibilities

    Interest in fluorogenic and reactive handle amino acids continues to rise. As industrial and academic research drifts toward ever more specialized modifications, we anticipate heavier demand for compounds like Fmoc-L-3-Cyanophenylalanine with strict stereochemical and chemical purity. Automation in both batch and continuous synthesis only elevates the need for predictable performance—dust, inconsistent crystallinity, and minor variance all add hidden costs that only careful manufacturing can avoid.

    Our technical development program now includes more comprehensive in-process analytics and ongoing investment in waste minimization and energy-efficient workflow. There is no one-size-fits-all solution in specialty amino acid production; every client and application brings up new technical wrinkles. We view each request for a nonstandard specification as a test of our team’s agility and a chance to push the limits of what specialty peptide chemistry can achieve.

    Conclusion: Building a Foundation for Discovery

    As a manufacturer, we don’t just supply Fmoc-L-3-Cyanophenylalanine—we invest in its ongoing evolution, knowing it represents a small but significant advance in what is chemically possible. Through attention to detail, rigorous process control, and honest communication, we allow researchers around the world to explore, innovate, and deliver breakthroughs. Our story with each product reflects the daily reality of technical challenge and personal accountability, and we remain committed to driving progress across the scientific community, one molecule at a time.